Virpax Pharmaceuticals (VRPX) announced that it will effect a 1-for-25 reverse stock split of its common stock, par value $0.0001 per share that will become effective at 12:01 a.m. Eastern Time on March 20. The Company’s Common Stock will continue to trade on the Nasdaq Capital Market under the symbol “VRPX” and will begin trading on a split-adjusted basis when the Nasdaq opens on March 21. The new CUSIP number for the Common Stock following the reverse split will be 928251305.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRPX:
- Virpax receives positive Probudur results for dose range study
- Virpax Pharmaceuticals files to sell common stock and warrants, no amount given
- Biotech Alert: Searches spiking for these stocks today
- Virpax Pharmaceuticals reports Molecular Envelope Technology human study data
- Virpax Pharmaceuticals confirms results with U.S. Army with Probudur